Bronchitis Archives - Clinical Advisor

ACP Offers Guidance on Antibiotic Duration for Common Infections

April 26, 2021

ACP recommends limiting antibiotic treatment duration to 5 days for COPD exacerbations and acute uncomplicated bronchitis.

Pediatrics Information Center

Recurrent Wheezing Risk in Infants Following Bronchiolitis Hospitalization

By

Virginia A. Schad, PharmD, RPh

July 28, 2020

Among infants with severe bronchiolitis, those with rhinovirus at hospitalization followed by a new rhinovirus infection had the highest risk of recurrent wheezing.

Middle-Aged patient learns to use inhaler

Pulmonology Information Center

COPD: Importance of Educating Patients on Proper Inhalation Technique

By

Erin Keller, MSN, APRN, FNP-BC, CCRN

Christy Catlett, MSN, APRN, FNP-C

Katherine Medina, APRN, FNP-C

Nancy Kern, EdD, MSN, APRN

Ann Lyons, PhD, MSN, RN, CNE

March 16, 2020

Practitioners can play a vital role in providing education and training on correct inhalation techniques to enhance therapeutic benefit and optimal medication delivery. Overall, the goal for the provider is to be confident when educating patients on proper use of inhalation technique, emphasize the importance of medication adherence, and maintain follow-up appointments.

Pediatrics Information Center

Bronchiolitis Hospitalization in Infancy Predicts More Admissions

March 18, 2019

More than 1 in 5 infants with a bronchiolitis hospital admission will have a subsequent respiratory-related hospital admission by age 5 years.

Web Exclusives

CDC, ACP issue guidelines for appropriate antibiotic use for acute respiratory tract infection in adults

By

Lauren Biscaldi

January 20, 2016

Reducing inappropriate antibiotic prescribing will improve the quality of patient care, decrease healthcare costs, and preserve the effectiveness of antibiotics.

Stat Consult

Stat Consult: Acute bronchitis

By

Alan Drabkin, MD

September 2, 2015

Learn how to diagnosis and treat acute bronchitis.

Drug Update

COPD therapy now available in pill form

August 27, 2011

Daliresp is a selective phosphodiesterase 4 inhibitor that reduces risk for chronic obstructive pulmonary disease exacerbations in severely effected patients with COPD that have chronic bronchitis and a history of exacerbations.

Advisor Forum

Inhaled steroid for bronchitis?

July 25, 2008

I see a number of non-asthmatic patients who use the corticosteroid/beta agonist combination fluticasone/salmeterol (Advair) on an as-needed basis for symptoms of uncomplicated acute viral bronchitis. Is there any validity to this use? Advair is also prescribed frequently for mild persistent asthma in lieu of an inhaled steroid. Am I off base in questioning this…